Minn. Pushes Back On Drug Cos.' Bid To Kill Insulin RICO Suit

Law360 (August 26, 2020, 5:25 PM EDT) -- Minnesota's attorney general has pushed back against three pharmaceutical giants trying to escape a suit accusing them of jacking up insulin prices, saying a New Jersey federal court wields the power to break up alleged schemes harming the public.

State Attorney General Keith Ellison urged the judge overseeing the case against Sanofi-Aventis US LLC, Novo Nordisk Inc. and Eli Lilly & Co. to preserve 12 counts under the federal Racketeer Influenced and Corrupt Organizations Act and one claim under Minnesota's False Statement in Advertising Act.

Tuesday's filing was a renewed effort by the North Star State to sue in civil court...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!